EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.7700
-0.0300 (-3.75%)
Apr 20, 2026, 3:25 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 36.24 million as of April 20, 2026. Its market cap has decreased by -48.26% in one year.
Market Cap
36.24M
Enterprise Value
21.69M
Revenue
61.40M
Ranking
n/a
PE Ratio
12.55
Stock Price
0.77
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 36.24M, a decrease of -25.61%. That is a compound annual growth rate of -5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 37.65M | -43.23% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 72.66M |
| Neurizon Therapeutics | 60.61M |
| Prescient Therapeutics | 53.63M |
| Imugene | 53.55M |
| Proteomics International Laboratories | 45.43M |
| Entropy Neurodynamics | 45.28M |
| NeuroScientific Biopharmaceuticals | 38.25M |
| Avecho Biotechnology | 34.90M |